ArticleCancer research and treatment2018

Intercalated Treatment Following Rebiopsy Is Associated with a Shorter Progression-Free Survival of Osimertinib Treatment.

Jeng-Sen Tseng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.